LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Automated Third Generation Assay Determines Parathyroid Hormone Levels

By LabMedica International staff writers
Posted on 13 Jul 2011
A chemiluminescent immunoassay was released for the quantitative determination of parathyroid hormone (PTH) levels.

The new assay, dubbed Liaison1-84 PTH, determines PTH in serum and ethylenediaminetetraacetic acid (EDTA)-plasma, without cross-reactivity with the 7-84 PTH fragment.

An antibody, which is highly specific for the N-terminus of the peptide ensures 100% specificity for the whole PTH molecule and eliminates the problem of interference due to N-terminal fragments. The Liaison1-84 PTH assay is therefore able to provide uniformity of results even in patients with kidney disease, who tend to accumulate these fragments in high concentrations.

DiaSorin (Turin, Italy) added the fully automated Liaison1-84 PTH assay to its bone and mineral panel, which includes Liaison 25-OH Vitamin D Total, Liaison N-TACT PTH, Liaison BAP Ostase, and Liaison Osteocalcin. The completed panel assesses and monitors bone metabolism diseases.

Related Links:

DiaSorin



New
Gold Member
STI Test
Vivalytic MG, MH, UP/UU
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Steam Sterilizer
Hi Vac II Line
New
Benchtop Thermomixer
Biometra TS1 ThermoShaker

Latest Immunology News

FDA Approval Expands Use of PD-L1 Companion Diagnostic in Esophageal and GEJ Carcinomas
13 Jul 2011  |   Immunology

Study Identifies Inflammatory Pathway Driving Immunotherapy Resistance in Bladder Cancer
13 Jul 2011  |   Immunology

Microfluidic Chip Detects Cancer Recurrence from Immune Response Signals
13 Jul 2011  |   Immunology



INTEGRA BIOSCIENCES AG